Table 1.

Differentially abundant metabolites selected between the BL and HA urine samples.

S. No	Metabolites	p Value	FC	VIP
1	Dihydrocaffeic acid 3-sulfate	0.000325	2.067	2.241
2	2-[3,5-dihydroxy-4-(sulfooxy)phenyl]acetic acid	0.001291	2.918	1.386
3	2-Tetrahydrothiopheneacetic acid	5.98E-05	3.589	2.438
4	Promazine 5-sulfoxide	0.000469	2.832	2.194
5	(1S,2S,4R)-1,8-Epoxy-p-menthan-2-ol glucoside	0.000117	4.301	2.135
6	Abacavir	2.69E-05	2.460	1.960
7	Trihomomethionine	0.000332	2.708	2.205
8	Methylxanthine	0.002985	3.950	1.690
9	Abietin	2.21E-05	3.041	2.270
10	p-Coumaric acid sulphate	0.001976	2.269	1.360
11	4,4′-Thiobis-2-butanone	5.80E−05	3.093	2.413
12	2-Hydroxyacetaminophen sulphate	0.000319	3.357	2.297
13	Etilevodopa	6.21E−05	2.770	2.265
14	1-Methyluric acid	0.003521	4.060	1.574
15	Tixocortol	0.000151	3.122	2.167
16	Ecgonine methyl ester	0.004361	2.011	1.801
17	Lycopsamine	0.001622	2.053	1.528
18	4,7-Dihydroxy-2,2-dimethyl-3,4-dihydro-2H-chromen-5-yl hexopyranosiduronic acid	0.0021	2.101	2.234
19	1-Benzyl-7,8-dimethoxy-3-phenyl-3H-pyrazolo[3,4-c]isoquinoline	0.000381	3.390	2.353
20	Dihomomethionine	0.000127	2.863	2.151
21	Dopamine 4-sulfate	1.21E−05	0.494	1.650
22	Azelaic acid	0.002116	0.456	1.997
23	Octanoylcarnitine	0.000275	0.440	2.004
24	Octanoylglucuronide	0.001587	0.437	1.687
25	Desethylchloroquine	0.002584	0.433	1.777
26	2-Hexenoylcarnitine	0.000543	0.429	1.510
27	4-Vinylphenol sulfate	0.003494	0.425	1.663
28	N-Acetyltryptophan	0.00155	0.424	1.919
29	Tetradecanedioic acid	0.00112	0.319	1.673
30	Trans-2-Dodecenoylcarnitine	0.001194	0.311	1.951
31	N-Acetyl-S-2-hydroxyethyl-l-cysteine	0.003307	0.305	1.960
32	N2-Acetylornithine	0.001668	0.249	1.689
33	Hydroxyisovaleroyl carnitine	0.000272	0.148	2.228

FC, fold change; VIP, variable importance in projection.